Misleading investors and the public about science is as serious as misstating financial information, life science company executives should know—now that a convicted drug-company ex-CEO has lost his last court appeal.
InterMune Inc. founder Dr. W. Scott Harkonen was convicted in 2009 of wire fraud for his role in creating and disseminating a press release publicizing the use of a drug to treat fatal lung disease that the drug wasn’t approved to treat. The U.S. Supreme Court again Nov. 5 refused to consider his case. It was the second time justices declined to review his appeal.
“If there is a ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.